stated that Zydus aims to globalize its medical device business, with a current focus on orthopedic implants, cardiology, and nephrology. Describing the medical device sector as a "sunrise sector ...

The government has recognised the medical device sector as a sunrise sector with strong growth potential, it stated. Zydus MedTech is focusing on high quality products and solutions for patients ...

March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new ... as part of its plans to expand further in the global medical devices market. The acquisition, which is a nearly 81% premium ...

Zydus sees significant opportunity for growth of the medical devices, both domestically and overseas, and is eyeing three segments—orthopaedics, interventional cardiology and nephrology.

Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., said: “We believe this was a natural extension in the field of medical technology. In Amplitude Surgical, we see several medium-term ...

(Reuters) -India's Zydus Lifesciences (ZYDUSLIFE.NS) said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA) for 256.8 million euros (nearly $280 million) as part of ...

Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...

The Government of India (GoI) has recognised the medical device sector as a sunrise sector with strong growth potential. Zydus MedTech is focusing on high quality products and solutions for ...

The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...

Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to produce the antifungal drug Ketoconazole Shampoo, 2%. The approval is valid for ...